Monday, May 29, 2023
Clinical Advances in HIV
Advances in antiretroviral therapy and HIV care have more than doubled the life expectancy of the more than 1.5 million people in the United States living with HIV. Healthcare providers are now managing HIV as a chronic disease in an aging population with common chronic health conditions. Better treatments as well as advances in HIV prevention are helping to stem the epidemic. This collection provides important information and perspectives on the latest advances in HIV treatment and care.
Supported by an independent educational grant from
ViiV Healthcare
Presented through a collaboration between Medscape and HealthHIV
Steering Committee Chair
Professor of Medicine
School of Medicine
University of North Carolina at Chapel Hill
Professor and Chair
Department of Clinical Services
Florida State University College of Medicine
Tallahassee, Florida
Assistant Professor of Medicine
Emory University School of Medicine
Atlanta, Georgia
Assistant Professor
Harvard Medical School
Brigham & Women's Hospital
Boston, Massachusetts
Professor and Chief
Infectious Diseases Division
Northwestern University
Chicago, Illinois
Professor of Medicine
Director
North Carolina AIDS Training and Education Center
Site Leader
UNC AIDS Clinical Trials Unit
University of North Carolina at Chapel Hill
Steering Committee Chair
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: Gilead Sciences, Inc.; Janssen Pharmaceuticals; Merck & Co., Inc.; ViiV Healthcare
Received grants for clinical research from: Gilead Sciences, Inc.; Janssen Pharmaceuticals; ViiV Healthcare
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: Merck & Co., Inc.; ViiV Healthcare
Has disclosed the following relevant financial relationships
Received grants for clinical research from: Gilead Sciences, Inc
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: Gilead Sciences, Inc.; GlaxoSmithKline; ViiV Healthcare
Received grants for clinical research from: GlaxoSmithKline; ViiV Healthcare
Has disclosed the following relevant financial relationships
Served as an advisor or consultant for: Gilead Sciences, Inc.; Health ViiV
Served as an advisor or consultant for: Gilead Sciences, Inc.; Janssen Pharmaceuticals; ViiV Healthcare
Received grants for clinical research from: Gilead Sciences, Inc.; ViiV Healthcare